Corporate Profiles On-line Consultancy Contact Us Site Map Newsletter Sign up  
 
    Home
    News
 
June-8-2006:
[IP] SunFAITH Conducted Raid Actions to ...
 
June-8-2006:
[IP]The Revising Draft of China¨s Tradem...
 
June-7-2006:
[Research] EXTRAVAGANZA Hit Shanghai Aga...
 
June-5-2006:
[IP] SunFAITH Initiate Enforcement again...
 
June-5-2006:
[IP] Application of Risk Management in B...
 
June-5-2006:
[Research] Sunfaith attend Workshop of M...
 
June-5-2006:
[IP] Company background Investigation --...
 
May-31-2006:
Newsletter May, 2006 Risk Management...
 
 
 
pharmaceutical regulatory service
Search
 

Intellectual Property Right
Risk Management
Industry Goods
Imaging Products
Medical and Pharmaceutical
Reset Send

Pharmaceutical Regulatory Service

Plan profitable business strategy and decisions led by pharmaceutical regulatory service of Sunfaith

Resolve disorders in market competition, chaos in pharmaceutical distribution and plan strategies to use the potential of China pharmaceutical market with pharmaceutical regulatory service of SunFaith. Sunfaith conducts research projects on market and its trends, sales, consumers, competitors etc. to produce reports, based on the research results. Sunfaith helps its pharmaceutical clients to take sound business strategies for marketing generics, OTC products, medical devices etc. through accurate and timely market reports and forecasts.

Sunfaith combines accurate facts based research results with its analysts' skills in pharmaceutical regulatory services to present professional analysis based reports. From forecasting trends, consumers' demands to providing early warning system of the potential threats from competitors - every report of Sunfaith is able to generate safe business decisions. An easy-to-read, standardized format and logical layout make complex characteristics of China pharmaceutical market easy to follow. Different market studies highlight different perspectives of market, assist in clear understanding of China pharmaceutical market.

Primarily, the pharmaceutical regulatory service emphasizes on identifying opportunity for market entry. 'Strategic and Market' entry analysis of Sunfaith will help pharmaceutical clients in this regard. The clients who hire Sunfaith to conduct research for market entry, get the benefits, like -

  • Identify the best prospects in the markets
  • Evaluate the best possible market entry strategies in details
  • Indicate the possible barriers to overcome for entering in the market
  • Recognize opportunities in market
  • Risk of threats from local as well as international companies in pharmaceutical market of China

Strategic reports along with market entry analysis help our clients with

  • Actionable conclusions and information
  • Analysis to frame responses for changing market
  • Strategies to respond to the changing competitions

Case Study:

A Norwegian pharmaceutical client entrusted Sunfaith to determine its opportunity in market. This company holds similar reputed position like Aventis, Alpharma, Merck, Novo Nordisk, WHO, UNICEF in producing metformin HCL and ferrous sulphate. We fed this company with detailed information on volume, trends, segments, competitors, prices, technical requirements, distribution channels. Through this study, the client expanded its business operations in China, understanding and evaluating the opportunities in market.

Our pharmaceutical regulatory service continues to serve the companies with protective and enforcement actions against pharmaceutical IP infringement in China. Where there is huge potential and capacity in the China pharmaceutical market, companies on the other hand face the threat of IP infringement. Between August and September of 2005, 440,000 counterfeit pharmaceutical products worth of 40 million yuan were captured. The IP protection of Sunfaith saves the pharmaceutical companies from counterfeiting of their patents and drugs.

Sunfaith helps clients in IP registration through its alliance with Trade Marks Office, the Trade Mark Review and Adjudication Board, the State Intellectual Property Office and the Patent Review Board. To control against faking clients' manufactured drugs, patents, designs, SunFaith offers IP investigation and research with the experience in wide range of IP matters. SunFaith also takes up enforcement actions against IP piracy such as administrative, civil, criminal and also through customs.

For smooth, successful and safe running of your pharmaceutical business, employ pharmaceutical regulatory service of SunFaith

 

Corporate Investigation China

 

Anti-Counterfeiting China | Benchmarking and Best Practice in China
Brand Protection China
| Business Intelligence Services China
Business Service Provider in China | China Business Strategy
China Government Relationship Consulting | China Industry and Market Report
China Intellectual Property Protection | China Trademark
Compliance Audit China | Conducting Business in China
Corporate Investigation China | Corporate Risk Services China
Due Diligence China | Employment Screening China
Healthcare Marketing Research China | Pharmaceutical Development Consulting
Pharmaceutical Regulatory Service | Starting a Business in China

 

    On-line consultancy    Home    Contact us  Site map   
China Business Tips     Press Release     China Websites     Site Guide